Registration Dossier
Registration Dossier
Data platform availability banner - registered substances factsheets
Please be aware that this old REACH registration data factsheet is no longer maintained; it remains frozen as of 19th May 2023.
The new ECHA CHEM database has been released by ECHA, and it now contains all REACH registration data. There are more details on the transition of ECHA's published data to ECHA CHEM here.
Diss Factsheets
Use of this information is subject to copyright laws and may require the permission of the owner of the information, as described in the ECHA Legal Notice.
EC number: 205-132-4 | CAS number: 134-20-3
- Life Cycle description
- Uses advised against
- Endpoint summary
- Appearance / physical state / colour
- Melting point / freezing point
- Boiling point
- Density
- Particle size distribution (Granulometry)
- Vapour pressure
- Partition coefficient
- Water solubility
- Solubility in organic solvents / fat solubility
- Surface tension
- Flash point
- Auto flammability
- Flammability
- Explosiveness
- Oxidising properties
- Oxidation reduction potential
- Stability in organic solvents and identity of relevant degradation products
- Storage stability and reactivity towards container material
- Stability: thermal, sunlight, metals
- pH
- Dissociation constant
- Viscosity
- Additional physico-chemical information
- Additional physico-chemical properties of nanomaterials
- Nanomaterial agglomeration / aggregation
- Nanomaterial crystalline phase
- Nanomaterial crystallite and grain size
- Nanomaterial aspect ratio / shape
- Nanomaterial specific surface area
- Nanomaterial Zeta potential
- Nanomaterial surface chemistry
- Nanomaterial dustiness
- Nanomaterial porosity
- Nanomaterial pour density
- Nanomaterial photocatalytic activity
- Nanomaterial radical formation potential
- Nanomaterial catalytic activity
- Endpoint summary
- Stability
- Biodegradation
- Bioaccumulation
- Transport and distribution
- Environmental data
- Additional information on environmental fate and behaviour
- Ecotoxicological Summary
- Aquatic toxicity
- Endpoint summary
- Short-term toxicity to fish
- Long-term toxicity to fish
- Short-term toxicity to aquatic invertebrates
- Long-term toxicity to aquatic invertebrates
- Toxicity to aquatic algae and cyanobacteria
- Toxicity to aquatic plants other than algae
- Toxicity to microorganisms
- Endocrine disrupter testing in aquatic vertebrates – in vivo
- Toxicity to other aquatic organisms
- Sediment toxicity
- Terrestrial toxicity
- Biological effects monitoring
- Biotransformation and kinetics
- Additional ecotoxological information
- Toxicological Summary
- Toxicokinetics, metabolism and distribution
- Acute Toxicity
- Irritation / corrosion
- Sensitisation
- Repeated dose toxicity
- Genetic toxicity
- Carcinogenicity
- Toxicity to reproduction
- Specific investigations
- Exposure related observations in humans
- Toxic effects on livestock and pets
- Additional toxicological data
Endpoint summary
Administrative data
Description of key information
Repeated Dose Toxicity Study (Oral):
No Observed Adverse Effect Level (NOAEL) is considered to be 500 mg / kg body weight when male and female rats were orally treated with test substance for chronic study.
Repeated Dose Toxicity Study (Dermal):
The acute toxicity value for the test chemical (as provided in section 7.2.3) is >5000 mg/kg body weight. Also, given the use of the chemical; repeated exposure by the dermal route is unlikely since the use of gloves is common practice in industries. Thus, it is expected that the test chemical shall not exhibit toxicity by the dermal route after repeated exposure. In addition, there is no data available that suggests that the test chemical would exhibit repeated dose toxicity by the dermal route. Hence this end point was considered for waiver.
Repeated Dose Toxicity Study (Inhalation):
The acute inhalation toxicity study need not be conducted because exposure to humans via inhalation route is not likely taking into account due to low vapour pressure of the test chemical, which is reported to be 1.599 Pa (0.012 mmHg). Thus, exposure to inhalable dust, mist and vapour of the chemical is highly unlikely. Therefore this study is considered for waiver.
Key value for chemical safety assessment
- Toxic effect type:
- dose-dependent
Repeated dose toxicity: via oral route - systemic effects
Link to relevant study records
- Endpoint:
- sub-chronic toxicity: oral
- Type of information:
- experimental study
- Adequacy of study:
- key study
- Reliability:
- 2 (reliable with restrictions)
- Rationale for reliability incl. deficiencies:
- data from handbook or collection of data
- Justification for type of information:
- Data is from publication
- Qualifier:
- according to guideline
- Guideline:
- other: As mentioned below
- Principles of method if other than guideline:
- 13 weeks repeated oral toxicity study of test chemical in rats.
- GLP compliance:
- not specified
- Limit test:
- no
- Species:
- rat
- Strain:
- Osborne-Mendel
- Details on species / strain selection:
- not specified
- Sex:
- male/female
- Details on test animals or test system and environmental conditions:
- TEST ANIMALS
- Source: not specified
- Females (if applicable) nulliparous and non-pregnant: [yes/no] not specified
- Age at study initiation: not specified
- Weight at study initiation: not specified
- Fasting period before study: not specified
- Housing: The animals were housed individually in wire cages
- Diet (e.g. ad libitum): ad libitum
- Water (e.g. ad libitum): ad libitum
- Acclimation period: not specified
DETAILS OF FOOD AND WATER QUALITY:
ENVIRONMENTAL CONDITIONS
- Temperature (°C): not specified
- Humidity (%): not specified
- Air changes (per hr): not specified
- Photoperiod (hrs dark / hrs light): not specified
IN-LIFE DATES: From: To:not specified - Route of administration:
- oral: gavage
- Details on route of administration:
- stomach tube
- Vehicle:
- corn oil
- Details on oral exposure:
- PREPARATION OF DOSING SOLUTIONS:
DIET PREPARATION
- Rate of preparation of diet (frequency): Fresh diets were made and distributed weekly
- Mixing appropriate amounts with (Type of food): The concentration of the solution was adjusted for each level so that all rats received a constant volume of 1 ml of solution/kg daily
- Storage temperature of food: Not specified
VEHICLE
- Justification for use and choice of vehicle (if other than water): The test chemical was soluble in corn oil
- Concentration in vehicle: Not specified
- Amount of vehicle (if gavage): Not specified
- Lot/batch no. (if required): Not specified
- Purity:Not specified - Analytical verification of doses or concentrations:
- not specified
- Details on analytical verification of doses or concentrations:
- not specified
- Duration of treatment / exposure:
- 13 weeks
- Frequency of treatment:
- Daily
- Dose / conc.:
- 0 mg/kg bw/day (nominal)
- Remarks:
- 0 ppm
- Dose / conc.:
- 50 mg/kg bw/day (nominal)
- Remarks:
- 1000 ppm
- Dose / conc.:
- 500 mg/kg bw/day (nominal)
- Remarks:
- 10000 ppm
- No. of animals per sex per dose:
- Total: 40 animals
Test group: 10 males and 10 females
Control group: 10 males and 10 females - Control animals:
- yes, concurrent vehicle
- Details on study design:
- Not specified
- Positive control:
- not specified
- Observations and examinations performed and frequency:
- The rat's weight, food intake and general condition were recorded every week. Haematological examinations were made at 3, 6, 12 and 22 months in the chronic experiments. These examinations included white cell counts, red cell counts, haemoglobins and haematocrits.
- Sacrifice and pathology:
- GROSS PATHOLOGY: Yes
HISTOPATHOLOGY: Yes
At the termination of the experiments the rats were sacrificed and exsanguinated - Other examinations:
- The tissues of all the rats were examined macroscopically at the time of sacrifice. The viscera were removed and the liver, kidneys, spleen, heart, and testes were weighed. These organs, the remaining abdominal and thoracic viscera, and one hind leg, for bone, bone marrow, and muscle, were preserved in 10 ~o buffered formalin-saline solution for histopathological examination. For routine histopathology, sections were embedded in paraffin wax and stained with haematoxylin and eosin. Tissues from rats dying during the experiment were examined for gross changes and were preserved if autolysis was not advanced. Organs were
not weighed but abnormalities and the suspected reason for death were noted. - Statistics:
- not specified
- Clinical signs:
- no effects observed
- Mortality:
- no mortality observed
- Body weight and weight changes:
- no effects observed
- Food consumption and compound intake (if feeding study):
- no effects observed
- Food efficiency:
- not specified
- Water consumption and compound intake (if drinking water study):
- not specified
- Ophthalmological findings:
- not specified
- Haematological findings:
- no effects observed
- Clinical biochemistry findings:
- no effects observed
- Urinalysis findings:
- not specified
- Behaviour (functional findings):
- not specified
- Immunological findings:
- not specified
- Organ weight findings including organ / body weight ratios:
- not examined
- Gross pathological findings:
- no effects observed
- Neuropathological findings:
- not specified
- Histopathological findings: non-neoplastic:
- not specified
- Histopathological findings: neoplastic:
- not specified
- Other effects:
- not specified
- Key result
- Dose descriptor:
- NOAEL
- Effect level:
- 500 mg/kg bw/day (nominal)
- Based on:
- test mat.
- Sex:
- male/female
- Basis for effect level:
- body weight and weight gain
- clinical signs
- food consumption and compound intake
- haematology
- mortality
- Remarks on result:
- not determinable due to absence of adverse toxic effects
- Critical effects observed:
- no
- Conclusions:
- No Observed Adverse Effect Level (NOAEL) is considered to be 500 mg / kg body weight when male and female rats were orally treated with test substance for chronic study.
- Executive summary:
13 weeks repeated oral toxicity study was performed on rats to determine the toxic nature of test chemical. The study was performed on 10 male and 10 female Osborne-Mendel rats, a control group containing the same number of rats as the test groups was included with test compound. The animals were housed individually in wire cages and had access to food and water at all times. The test chemical was administered via stomach tube in corn oil solution at a dose range of 0, 1,000 and 10,000 ppm (approximately equivalent to 50 and 500 mg/kg bw). The concentration of the solution was adjusted for each level so that all rats received a constant volume of 1 ml of solution/kg daily. The control animals were given an equal volume of corn oil. The rat's weight, food intake and general condition were recorded every week. Hematological examinations were made at 3, 6, 12 and 22 months. These examinations included white cell counts, red cell counts, hemoglobin and hematocrits. At the termination of the experiments the rats were sacrificed and exsanguinated. The tissues of all the rats were examined macroscopically at the time of sacrifice. The viscera were removed and the liver, kidneys, spleen, heart, and testes were weighed. These organs, the remaining abdominal and thoracic viscera, and one hind leg, for bone, bone marrow, and muscle, were preserved in 10 % buffered formalin-saline solution for histopathological examination. For routine histopathology, sections were embedded in paraffin wax and stained with haematoxylin and eosin. Tissues from rats dying during the experiment were examined for gross changes and were preserved if autolysis was not advanced. Organs were not weighed but abnormalities and the suspected reason for death were noted. After 13 weeks, No adverse effects were observed on body weights, appearance, food intake, hematology, organ weights, macroscopic or microscopic (at highest dietary level) examination of the major organs. Pathological changes attributable to disease or age were observed. Thus based on observations, No Observed Adverse Effect Level (NOAEL) is considered to be 500 mg / kg body weight indicating that the test chemical is not toxic in nature.
Reference
Endpoint conclusion
- Endpoint conclusion:
- no adverse effect observed
- Dose descriptor:
- NOAEL
- 500 mg/kg bw/day
- Study duration:
- chronic
- Species:
- rat
- Quality of whole database:
- Data is from a Klimisch 2 database.
Repeated dose toxicity: inhalation - systemic effects
Endpoint conclusion
- Endpoint conclusion:
- no study available
Repeated dose toxicity: dermal - systemic effects
Endpoint conclusion
- Endpoint conclusion:
- no study available
Additional information
Repeated Dose (Oral) Toxicity:
The data of the repeated dose toxicity of the test chemicals is as follows:
A 13 weeks repeated oral toxicity study was performed on rats to determine the toxic nature of test chemical. The study was performed on 10 male and 10 female Osborne-Mendel rats, a control group containing the same number of rats as the test groups was included with test compound. The animals were housed individually in wire cages and had access to food and water at all times. The test chemical was administered via stomach tube in corn oil solution at a dose range of 0, 1,000 and 10,000 ppm (approximately equivalent to 50 and 500 mg/kg bw). The concentration of the solution was adjusted for each level so that all rats received a constant volume of 1 ml of solution/kg daily. The control animals were given an equal volume of corn oil. The rat's weight, food intake and general condition were recorded every week. Hematological examinations were made at 3, 6, 12 and 22 months. These examinations included white cell counts, red cell counts, hemoglobin and hematocrits. At the termination of the experiments the rats were sacrificed and exsanguinated. The tissues of all the rats were examined macroscopically at the time of sacrifice. The viscera were removed and the liver, kidneys, spleen, heart, and testes were weighed. These organs, the remaining abdominal and thoracic viscera, and one hind leg, for bone, bone marrow, and muscle, were preserved in 10 % buffered formalin-saline solution for histopathological examination. For routine histopathology, sections were embedded in paraffin wax and stained with haematoxylin and eosin. Tissues from rats dying during the experiment were examined for gross changes and were preserved if autolysis was not advanced. Organs were not weighed but abnormalities and the suspected reason for death were noted. After 13 weeks, No adverse effects were observed on body weights, appearance, food intake, hematology, organ weights, macroscopic or microscopic (at highest dietary level) examination of the major organs. Pathological changes attributable to disease or age were observed. Thus based on observations, No Observed Adverse Effect Level (NOAEL) is considered to be 500 mg / kg body weight indicating that the test chemical is not toxic in nature.
Similarly, 115 days repeated oral toxicity study was performed on rats to determine the toxic nature of test chemical. The study was performed on 10 male and 10 female weanling rats. The test animals were given diets containing test chemical at a concentration of 0, 3000 or 10 000 mg/kg of diet, approximately equivalent to 0, 150-300 and 500-1000 mg/kg bw per day, respectively. During the observation period there was no evidence of adverse effects at 3000 ppm, as judged by appearance, behaviour, growth, mortality, terminal haematological examination, final body weights and gross and microscopic examination. The only effects observed at 10 000 ppm were increased average weights of the liver and kidneys and slight (minimal) histological changes in the kidneys. Thus based on observations, the No Observed Effect Level (NOEL) of the test chemical was determined to be 150 mg/kg bw indicating that the test chemical is not toxic in nature.
Repeated Dose Toxicity Study (Dermal):
The acute toxicity value for the test chemical (as provided in section 7.2.3) is >5000 mg/kg body weight. Also, given the use of the chemical; repeated exposure by the dermal route is unlikely since the use of gloves is common practice in industries. Thus, it is expected that the test chemical shall not exhibit toxicity by the dermal route after repeated exposure. In addition, there is no data available that suggests that the test chemical would exhibit repeated dose toxicity by the dermal route. Hence this end point was considered for waiver.
Repeated Dose Toxicity Study (Inhalation):
The acute inhalation toxicity study need not be conducted because exposure to humans via inhalation route is not likely taking into account due to low vapour pressure of the test chemical, which is reported to be 1.599 Pa (0.012 mmHg). Thus, exposure to inhalable dust, mist and vapour of the chemical is highly unlikely. Therefore this study is considered for waiver.
Justification for classification or non-classification
Based on the above information and CLP criteria for the test chemical, the test chemical is not likely to exhibit toxicity upon repeated exposure by oral, inhalation and dermal route.
Information on Registered Substances comes from registration dossiers which have been assigned a registration number. The assignment of a registration number does however not guarantee that the information in the dossier is correct or that the dossier is compliant with Regulation (EC) No 1907/2006 (the REACH Regulation). This information has not been reviewed or verified by the Agency or any other authority. The content is subject to change without prior notice.
Reproduction or further distribution of this information may be subject to copyright protection. Use of the information without obtaining the permission from the owner(s) of the respective information might violate the rights of the owner.